These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6520402)

  • 1. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.
    Mao SJ; France DS
    J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-free medium for the growth of NS-1 mouse myeloma cells and the isolation of NS-1 hybridomas.
    Kawamoto T; Sato JD; McClure DB; Sato GH
    Methods Enzymol; 1986; 121():266-77. PubMed ID: 3724465
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas.
    Kawamoto T; Sato JD; Le A; McClure DB; Sato GH
    Anal Biochem; 1983 Apr; 130(2):445-53. PubMed ID: 6869833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved fusion technique. II. Stability and purity of hybrid clones.
    Westerwoudt RJ; Naipal AM; Harrisson CM
    J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium.
    Yabe N; Matsuya Y; Yamane I; Takada M
    In Vitro Cell Dev Biol; 1986 Jul; 22(7):363-8. PubMed ID: 3733634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical properties of human low density lipoproteins as explored by monoclonal antibodies. Binding characteristics distinct from those of conventional serum antibodies.
    Mao SJ; Kazmar RE; Silverfield JC; Alley MC; Kluge K; Fathman CG
    Biochim Biophys Acta; 1982 Nov; 713(2):365-74. PubMed ID: 6185154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous cloning and selection of hybridomas and transfected cell lines in semisolid media.
    Wognum B; Lee T
    Methods Mol Biol; 2013; 946():133-49. PubMed ID: 23179830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical method for rescuing desired hybridomas during monoclonal antibody production.
    Adamus G; Zam ZS; Emerson SS; Hargrave PA
    In Vitro Cell Dev Biol; 1989 Dec; 25(12):1141-6. PubMed ID: 2691498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-mitogen containing conditioned medium for hybridoma production and single cell cloning.
    Apiratmateekul N; Pata S; Chiampanichayakul S; Kasinrerk W
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):114-22. PubMed ID: 22830290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free medium for murine and human lymphoid and hybridoma cell lines.
    Togami M; Yasuda K; Kariya M
    Cytotechnology; 1991 May; 6(1):33-8. PubMed ID: 1367398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Cloning of Hybridoma Cells by Limiting Dilution.
    Greenfield EA
    Cold Spring Harb Protoc; 2019 Nov; 2019(11):. PubMed ID: 31676581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium.
    Schneider YJ
    J Immunol Methods; 1989 Jan; 116(1):65-77. PubMed ID: 2644356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient hybridoma production using previously frozen splenocytes.
    Marusich MF
    J Immunol Methods; 1988 Nov; 114(1-2):155-9. PubMed ID: 3183388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.
    Parks DR; Bryan VM; Oi VT; Herzenberg LA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1962-6. PubMed ID: 287037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of insulin-enriched culture medium and human-human hybridoma formation: a preliminary study.
    Bartal AH; Feit C; Hirshaut Y
    Acta Haematol; 1986; 76(1):50-3. PubMed ID: 3098027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies.
    Davis JM; Pennington JE; Kubler AM; Conscience JF
    J Immunol Methods; 1982; 50(2):161-71. PubMed ID: 7086152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step freezing of cells used in hybridoma technology.
    Pĕknicová J; Landa V
    Folia Biol (Praha); 1985; 31(5):340-7. PubMed ID: 4065374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-free medium for growth factor-dependent and -independent plasmacytomas and hybridomas.
    Shacter E
    J Immunol Methods; 1987 May; 99(2):259-70. PubMed ID: 3584996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-free medium for hybridoma and parental myeloma cell cultivation.
    Kovár J; Franĕk F
    Methods Enzymol; 1986; 121():277-92. PubMed ID: 3523123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.